Quest diagnostics incorporated DGX.US 總覽分析
)DGX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，股利評分名列前茅，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
DGX 近期報酬表現
-1.32%
Quest diagnostics incorporated
4.69%
同產業平均
-0.56%
S&P500
與 DGX 同產業的標的表現
- LH Labcorp holdings inc價值 4 分趨勢 3 分波段 5 分籌碼 5 分股利 1 分查看更多
DGX 公司資訊
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company's services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.